Methods and systems for predicting response to anti-TNF therapies
US11198727B2 · kind B2 · utility
2Cited by
19References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2019 |
| Grant date | Dec 14, 2021 |
| Priority date | — |
| Expiry date | Apr 25, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H50/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods and systems for administering anti-TNF therapy to subjects who have been determined to display a gene expression response signature established to distinguish between responsive and non-responsive prior subjects who have received the anti-TNF therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.